Fewer Wuhan Patients For Gilead Remdesivir Study: WHO
China Coronavirus Studies Surge
In a shocking and revealing account, a primary investigator of the front-runner antiviral drug for the coronavirus in China expresses concerns over finding enough patients for the study Wuhan, the outbreak's epicenter.
